Name: Latest research reports of Dr. Reddy's Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Dr. Reddy's Laboratories Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report	Discuss
	18 Sep 2025	Dr. Reddy's Labs	Consensus Share Price Target	1322.70	1285.13	-	-2.84	hold	pdf Detailed Estimates
	22 Jun 2022	Dr. Reddy's Labs	BOB Capital Markets Ltd.	1322.70	4450.00	4309.65 (-69.31%)	Target met	Hold	pdf post cache	Broker Report Dr Reddy's Labs (HOLD): Investor Day Peek into the future BOB Capital Markets Ltd. DRRD unveiled a framework to make its business future ready pdf Copy Link Share on Share on Share on Share on Alert
	21 May 2022	Dr. Reddy's Labs	Sharekhan Target	1322.70	5550.00	4390.50 (-69.87%)	Pre-Bonus/ Split	Buy	pdf post cache	Broker Report Dr Reddys Labs Sharekhan pdf Copy Link Share on Share on Share on Share on Alert
	20 May 2022	Dr. Reddy's Labs	BOB Capital Markets Ltd. Target	1322.70	4450.00	4249.10 (-68.87%)	Target met	Hold	pdf post cache	Broker Report Dr Reddy's Labs (HOLD): Operating performance in line; impairment weighs down profit BOB Capital Markets Ltd. India, Russia, US and one-off opportunities drove 15% YoY sales growth in Q4; non-core brands divested in Russia and India pdf Copy Link Share on Share on Share on Share on Alert
	20 May 2022	Dr. Reddy's Labs	ICICI Direct	1322.70	4800.00	4249.10 (-68.87%)	Target met	Buy	pdf post cache	Broker Report Dr Reddy's Laboratories ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	20 May 2022	Dr. Reddy's Labs	Axis Direct Target	1322.70	4500.00	4249.10 (-68.87%)	Target met	Buy	pdf post cache	Broker Report Result Update:Dr Reddys Labs Axis Direct The company is building a global pipeline of biosimilars, developments of NCE for Immuno-oncology, and building up a Neutraceuticals portfolio, vaccines, CDMO, and digital healthcare platforms. However, high inflation could decrease margins prompting us to reduce TP to Rs 4,500/share. pdf Copy Link Share on Share on Share on Share on Alert
	20 May 2022	Dr. Reddy's Labs	Motilal Oswal Reco Target	1322.70	4800.00	4249.10 (-68.87%)	Target met	Buy	pdf post cache	Broker Report Efforts on track to sustain robust launches across markets Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	20 May 2022	Dr. Reddy's Labs	ICICI Direct	1322.70	4800.00	4249.10 (-68.87%)	Target met	Buy	pdf post cache	Broker Report Ashok Leyland ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	20 May 2022	Dr. Reddy's Labs	SMC online	1322.70		4249.10 (-68.87%)	Pre-Bonus/ Split	Results Update	pdf post cache	Broker Report Dr. Reddy`s Laboratories SMC online pdf Copy Link Share on Share on Share on Share on Alert
	31 Jan 2022	Dr. Reddy's Labs	BOB Capital Markets Ltd. Target	1322.70	4700.00	4302.80 (-69.26%)	Pre-Bonus/ Split	Hold	pdf post cache	Broker Report Dr Reddy's Labs (HOLD): Stable quarter, US price erosion continues; cut to HOLD BOB Capital Markets Ltd. Growth in Q3 driven by product launches and higher volumes, partly offset by US price erosion pdf Copy Link Share on Share on Share on Share on Alert
	29 Jan 2022	Dr. Reddy's Labs	ICICI Securities Limited Reco Target	1322.70	5160.00	4218.60 (-68.65%)	Pre-Bonus/ Split	Buy	pdf post cache	Broker Report Dr Reddy's Laboratories ICICI Securities Limited Numbers in line; launches in FY23 likely drivers APIs, custom pharmaceutical services, biosimilar and complex formulations. It has 13 formulation facilities, nine API manufacturing facilities, one biologics facility and several R&D centres across the globe Q3FY22 Results: Reported steady set of numbers despite Covid revenue vacuum this quarter, in line with our estimates.... pdf Copy Link Share on Share on Share on Share on Alert
more loading

29.68% Gain from 52W Low

Dr. Reddy's Laboratories Ltd. share price target

Dr. Reddy's Laboratories Ltd. has an average share price target of 1278.56. The consensus estimate represents a downside of -3.34% from the last price of 1322.70. View 18 reports from 9 analysts offering long-term price targets for Dr. Reddy's Laboratories Ltd..

Dr Reddy's Labs (HOLD): Investor Day Peek into the future

Dr Reddys Labs

Dr Reddy's Labs (HOLD): Operating performance in line; impairment weighs down profit

Dr Reddy's Laboratories

Result Update:Dr Reddys Labs

Efforts on track to sustain robust launches across markets

Ashok Leyland

Dr. Reddy`s Laboratories

Dr Reddy's Labs (HOLD): Stable quarter, US price erosion continues; cut to HOLD

Dr Reddy's Laboratories

Advisor Screeners